相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and perfusion in patients with short bowel syndrome: Findings from a randomized phase 2 trial
Rahim M. Naimi et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2023)
Novel therapeutic targets for cholestatic and fatty liver disease
Michael Trauner et al.
GUT (2022)
Ring Trial on Quantitative Assessment of Bile Acids Reveals a Method- and Analyte-Specific Accuracy and Reproducibility
Sven-Bastiaan Haange et al.
METABOLITES (2022)
NR4A1 inhibits the epithelial-mesenchymal transition of hepatic stellate cells: Involvement of TGF-β-Smad2/3/4-ZEB signaling
Qian Huang et al.
OPEN LIFE SCIENCES (2022)
Human gastrointestinal epithelia of the esophagus, stomach, and duodenum resolved at single-cell resolution
Georg A. Busslinger et al.
CELL REPORTS (2021)
The Spectrum of Reactive Cholangiocytes in Primary Sclerosing Cholangitis
Maria Eugenia Guicciardi et al.
HEPATOLOGY (2020)
Loss of Glp2r signaling activates hepatic stellate cells and exacerbates diet-induced steatohepatitis in mice
Shai Fuchs et al.
JCI INSIGHT (2020)
Activated hepatic stellate cells and portal fibroblasts contribute to cholestatic liver fibrosis in MDR2 knockout mice
Takahiro Nishio et al.
JOURNAL OF HEPATOLOGY (2019)
4 in 1: Antibody-free protocol for isolating the main hepatic cells from healthy and cirrhotic single rat livers
Anabel Fernandez-Iglesias et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Localization of Glucagon-Like Peptide-2 Receptor Expression in the Mouse
Bernardo Yusta et al.
ENDOCRINOLOGY (2019)
Role of inflammation and proinflammatory cytokines in cholangiocyte pathophysiology
Claudio Pinto et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
The protective and anti-inflammatory effects of a modified glucagon-like peptide-2 dimer in inflammatory bowel disease
Jintao Gu et al.
BIOCHEMICAL PHARMACOLOGY (2018)
Single-cell spatial reconstruction reveals global division of labour in the mammalian liver
Keren Bahar Halpern et al.
NATURE (2017)
Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway
Bernardo Yusta et al.
MOLECULAR METABOLISM (2017)
Glucagon-Like Peptide-2 Alters Bile Acid Metabolism in Parenteral Nutrition-Associated Liver Disease
David W. Lim et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2016)
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis
Anna Baghdasaryan et al.
JOURNAL OF HEPATOLOGY (2016)
Roux-en-Y Gastric Bypass and Vertical Banded Gastroplasty InduceLong-Term Changes on the Human Gut Microbiome Contributing to Fat Mass Regulation
Valentina Tremaroli et al.
CELL METABOLISM (2015)
Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis
Katrin Palumbo-Zerr et al.
NATURE MEDICINE (2015)
Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration
Noura El-Jamal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Characterization of animal models for primary sclerosing cholangitis (PSC)
Peter Fickert et al.
JOURNAL OF HEPATOLOGY (2014)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Ingmar Mederacke et al.
NATURE COMMUNICATIONS (2013)
Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome
P. B. Jeppesen et al.
GUT (2011)
Curcumin improves sclerosing cholangitis in Mdr2-/- mice by inhibition of cholangiocyte inflammatory response and portal myofibroblast proliferation
Anna Baghdasaryan et al.
GUT (2010)
A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis
Peter Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis
L Xu et al.
GUT (2005)
Regurgitation of bile acids from leaky sclerosing cholangitis in Mdr2 (Abcb4) bile ducts causes knockout mice
P Fickert et al.
GASTROENTEROLOGY (2004)
The cholangiopathies: Disorders of biliary epithelia
KN Lazaridis et al.
GASTROENTEROLOGY (2004)
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice
M Wagner et al.
GASTROENTEROLOGY (2003)